Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance

eLife(2024)10.7554/elife.94903Source: DataRank Database

Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance is a research paper published in eLife (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (43)IDs (PubMed)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Mehmet A. Orman ORCID,Rauf Shiraliyev

Live enrichment

PubMed:39093940

National Science Foundation

Grant: 2044375

CAREER: Characterizing Persister Cell Metabolism in Bacteria

National Institute of Allergy and Infectious Diseases

Grant: AI143643

NIH/NIAID

Grant: R01-AI143643

National Institutes of Health

Grant: 5R01AI143643-03

Characterizing a Self-Digesting-Mediated Reversible Drug Tolerance Mechanism in Bacteria

NIAID NIH HHS

Grant: R01 AI143643

goldLicense: cc-by

publisherhttps://doi.org/10.7554/elife.94903

publisherhttps://cdn.elifesciences.org/articles/94903/elife-94903-v1.pdf

publisherhttps://cdn.elifesciences.org/articles/94903/elife-94903-v1.xml

publisherhttps://elifesciences.org/articles/94903

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11296704/pdf/elife-94903.pdf

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciencesRibosomal ProteinsAminoglycosidesAnti-Bacterial AgentsEscherichia coliEnergy MetabolismEscherichia coli ProteinsDrug ToleranceProteomicsCitric Acid Cycle

MeSH Terms

Ribosomal ProteinsAminoglycosidesAnti-Bacterial AgentsEscherichia coliEnergy MetabolismEscherichia coli ProteinsDrug ToleranceProteomicsCitric Acid Cycle

Keywords

Ribosomal ProteinsProteomicsQH301-705.5ScienceCitric Acid Cycleantibiotic toleranceArticleenergy metabolismEscherichia coliBiology (General)Microbiology and Infectious DiseaseEscherichia coli ProteinsQRDrug ToleranceAnti-Bacterial AgentsAminoglycosidesaminoglycosideMedicineE. coliinfectious diseasemicrobiology

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good health